Our Stocks to Watch today include Capital Growth Systems, Inc. (OTCBB: CGSY), Solar Night Industries (OTC: SLND), DOR BioPharma, Inc.(OTCBB: DORB), Wireless Age Communications, Inc. (OTCBB: WLSA)
Visit http://www.otcpicks.com/ to register for our Daily Market Mover’s Digest Newsletter, and Email Stock Watch Alerts.
CAPITAL GROWTH SYSTEMS (OTCBB: CGSY)
"Up 32.76% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/CGSY.php
Capital Growth Systems, Inc., doing business as Global Capacity Group, Inc., delivers telecom integration services to systems integrators, telecommunications companies, and enterprise customers worldwide. It provides an integrated supply chain management system that streamlines and accelerates the process of designing, building, and managing customized communications networks. The company also provides connectivity services for network integrators who bundle telecommunication solutions to enterprise customers; offers global pricing and quotation software and management services for data communications; and assists customers to reduce connectivity costs and attain understanding and control of their deployed communications network. In addition, the company manages data replication and business continuity environments for multinational corporations and health care institutions. Capital Growth Systems is based in Chicago, Illinois.
CGSY News:
January 3 - Global Capacity and VSNL Global Services Complete Strategic Sourcing Agreement
Partnership Provides Company with Crucial International NOC, Provisioning and Analyst Resources
Global Capacity, Inc., a subsidiary of Capital Growth Systems, Inc. (OTCBB: CGSY) and the telecom industry’s first logistics company, announced that it has signed a strategic sourcing contract with VSNL Global Services Limited (parent: Videsh Sanchar Nigam Limited (NYSE: VSL)), a global leader in outsourced carrier operations.
This agreement enables Global Capacity to efficiently scale operations through the establishment of an international network operations center (NOC), as well as utilize additional network analyst and provisioning resources.
“A high quality, scalable service delivery capability is critical to support the rapid adoption of our solutions by our expanding global customer base,” said Patrick Shutt, Chief Executive Officer for Global Capacity. “By coupling the resources and capabilities of VSNL Global Services Limited with the core expertise and systems of Global Capacity, we have created a cost effective service delivery capability that exceeds our customer’s expectations both immediately and into the future.”
The international operations center, located in Pune, India, will work in conjunction with the Global Capacity network operations center in Waltham, MA, to provide “follow the sun” support for the Company’s increasingly international customer base. The network analyst and provisioning resources will enable the rapid scaling required to implement key customer revenue initiatives as Global Capacity continues to win major contracts.
Additionally, Global Capacity and VSNL Global Services Limited have signed a Letter of Intent to create a business development agreement that enables each company to leverage the other’s portfolio of offerings to its existing customer base.
“We are pleased that Patrick and his team have chosen VSNL Global Services Limited as their strategic sourcing partner,” said V. S. Shridhar, Chief Operations Officer of VSNL Global Services Limited. “We believe Global Capacity has developed a unique model and has an unrivaled group of talented industry experts that are creating tremendous value in the market. There are strong similarities in how our two companies do business, and VGSL is very well positioned to help Global Capacity successfully manage its rapid growth.”
ABOUT GLOBAL CAPACITY
Global Capacity is the operating arm of Capital Growth Systems, Inc. (OTCBB: CGSY). The telecom logistics company provides a fully integrated supply chain management system that streamlines and accelerates the process of designing, building and managing customized communications networks. It offers a comprehensive suite of services to enterprises, systems integrators and carrier customers worldwide. Global Capacity has operational centers in Waltham, MA; Manchester, England and Houston, TX; with offices in Chicago, IL; New York, NY; Minneapolis, MN; and Lisbon, Portugal. For more information, visit http://www.globalcapacity.com/ or contact (866) 226-4244.
SOLAR NIGHT INDUSTRIES (OTC: SLND)
"Up 16.22% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SLND.php
Solar Night Industries, Inc. is a national Modern Energy Company that enables residential and commercial energy users to implement cost-effective, renewable energy solutions that help them reduce their dependence on traditional energy sources, reducing Co2 emissions. Solar Night Industries, Inc. is based in St. Louis, Missouri (USA). For more information, visit http://www.solarnightindustries.com/.
SLND News:
January 2 - Solar Night Industries Offers Unique Program to Jump-Start New Home Sales
Solar Night Industries (OTC: SLND), a renewable energy company formed to accelerate the adoption of Modern Energy Solutions, introduces the Solar Synapse(TM), a product, sales and marketing program designed to capitalize on the burgeoning demand for renewable energy alternatives among potential new homeowners. According to a recent Roper survey commissioned by Sharp Electronics Corporation, nearly 90 percent of Americans think that solar electricity should be an option for all new home construction. Three-quarters of survey respondents perceive solar power to be more important than ever, evidence that Americans recognize the value of solar as a modern, renewable form of energy.
The Solar Synapse Pre-Wire Kit is part of an overall program designed to empower homeowners to add energy efficiency in the future. The Kit, installed during construction, will prepare a new home for adding photovoltaic solar panels (electricity) at some future date. With new federal, state and local subsidies changing and the price of solar panels projected to halve in the next five years, the timing is perfect to make these new homes "solar ready" now. The program includes marketing materials to help the builder sell Pre-Wire Kits and provides a post-purchase activity for the new homeowner. After closing, new owners can go to the Solar Synapse (TM) site to register their kit. They will receive a copy of a "The Homeowner's Guide to Renewable Energy," plus they qualify to receive a Modern Energy Plan(TM) from SNI for their home. The revolutionary Modern Energy Plan(TM) is a customized plan that will tell them the cost to complete the total solar system, plus, educate the consumer regarding the incentives in their area.
"We feel the Solar Synapse(TM) is a unique solution for builders who seek to differentiate their business and attract the mainstreaming green market. Education is an important aspect of our business model and we believe this program teaches builders about the potential of using modern energy solutions as a best-practice, and educating the homeowner regarding their options," says Tim Corbet, CEO of Solar Night.
Solar Night is expanding the Solar Synapse(TM) product rollout via a network of Manufacturer's Representatives' from the building and renewable energy segments. For more information, go to http://www.solarsynapse.com/.
DOR BIOPHARMA INCORPORATED (OTCBB: DORB)
"Up 13.16% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/DORB.php
DOR BioPharma, Inc., a biopharmaceutical company, engages in the research and development of oral therapeutic products intended for areas of unmet medical needs and biodefense vaccines in the United States and internationally. It operates through two segments, BioTherapeutics and BioDefense. The BioTherapeutics segment develops orBec, an orally administered corticosteroid that exerts a potent and local anti-inflammatory effect in the mucosal tissue of the gastrointestinal tract; Oraprine, an oral suspension of azathioprine; and LPE and PLP systems for delivery of water-insoluble drugs. The BioDefense segment offers RiVax, ricin toxin vaccine, a heat stable toxin that is isolated and purified from the bean of the castor plant; and BT-VACC, the Botulinum toxin, a poisonous natural substance that causes acute, symmetric, and descending flaccid paralysis due to its action on peripheral cholinergic nerves. The company was founded in 1987 and is based in Ewing, New Jersey.
DORB News:
January 3 - DOR BioPharma Receives Orphan Drug Designation for Oral BDP for the Treatment of Pediatric Crohn's Disease
Treatment Could Benefit Approximately 100,000 Pediatric Patients in the US Afflicted With Crohn's Disease
DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company") announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Oral BDP (beclomethasone dipropionate) for the treatment of pediatric Crohn's disease.
The US Orphan Drug Act is intended to assist and encourage companies to develop safe and effective therapies for the treatment of rare diseases and disorders. In addition to providing a seven year term of market exclusivity for Oral BDP upon final FDA approval, orphan drug designation also positions DOR to be able to take advantage of a wide range of financial and regulatory benefits, including government grants for conducting clinical trials, waiver of expensive FDA user fees for the potential submission of a New Drug Application for Oral BDP, and certain tax credits.
Oral BDP is a highly potent, topically active corticosteroid that has a local effect on inflamed tissue. BDP has been marketed in the United States and worldwide since the early 1970s as the active pharmaceutical ingredient in inhalation products for the treatment of patients with allergic rhinitis and asthma. BDP is also the active ingredient in orBec®, currently in development by DOR for the treatment and prevention of Graft-versus-Host disease (GVHD).
"The FDA's decision to grant Oral BDP Orphan Drug Designation for the treatment of pediatric Crohn's disease signifies an important step for DOR as we begin to expand our pipeline with Oral BDP into other important indications beyond GVHD," stated Christopher J. Schaber, PhD, President and CEO of DOR BioPharma. "We anticipate that pediatric Crohn's disease will be the first of several new Orphan Drug Designations both in the US and in Europe as we work to maximize the global value of our Oral BDP and orBec® franchise. We believe that Oral BDP has the potential to be of significant benefit to pediatric Crohn's disease patients."
ABOUT PEDIATRIC CROHN’S DISEASE
Crohn's disease is an ongoing disorder that causes inflammation of the gastrointestinal (GI) tract. Crohn's disease can affect any area of the GI tract, from the mouth to the anus, but it most commonly affects the lower part of the small intestine, called the ileum. The swelling caused by the disease extends deep into the lining of the affected organ. The swelling can induce pain and can make the intestines empty frequently, resulting in diarrhea. Because the symptoms of Crohn's disease are similar to other intestinal disorders, such as irritable bowel syndrome and ulcerative colitis, it can be difficult to diagnose. People of Jewish heritage have an increased risk of developing Crohn's disease.
Crohn's disease can appear at any age, but it is most often diagnosed in adults in their 20s and 30s. However, approximately 30% of people with Crohn's disease develop symptoms before 20 years of age. Pediatric Crohn's disease is a subpopulation of patients 0-19 years of age who suffer from Crohn's disease. In the United States, about 100,000 teens and preteens have Crohn's disease.
Crohn's disease presents special challenges for children and teens. In addition to bothersome and often painful symptoms, the disease can stunt growth, delay puberty, and weaken bones. Crohn's disease symptoms may sometimes prevent a child from participating in enjoyable activities. The emotional and psychological issues of living with a chronic disease can be especially difficult for young people.
ABOUT ORAL BDP
Beclomethasone dipropionate is a highly potent, topically active corticosteroid and is the active ingredient in orBec®, DOR's product candidate for the treatment of gastrointestinal Graft-versus-Host disease (GI GVHD), a common disorder among immunocompromised cancer patients after receiving allogeneic stem cell or bone marrow transplants. Like pediatric Crohn's disease, GI GVHD is also an inflammatory condition of the GI tract. Patients with mild-to-moderate GI GVHD typically develop symptoms of anorexia, nausea, vomiting and diarrhea.
DOR has previously run two randomized, double-blinded, placebo-controlled clinical trials in GI GVHD with orBec®. The first trial was a 60-patient Phase 2 single-center clinical trial conducted at the Fred Hutchinson Cancer Research Center. The second trial was a 129-patient pivotal Phase 3 multi-center clinical trial conducted at 16 leading bone marrow/stem cell transplant centers in the United States and France. Although orBec® did not achieve statistical significance in the primary endpoint of its pivotal trial, namely median time to treatment failure through Day 50 (p-value 0.1177), orBec® did achieve statistical significance in other key secondary endpoints such as median time to treatment failure through Day 80 (p-value 0.0226), as well as a 66% reduction in mortality among patients randomized to orBec® at 200 days post-transplant with only five patient (8%) deaths in the orBec® group compared to 16 patient (24%) deaths in the placebo group (p-value 0.0139). At one year post randomization in the pivotal Phase 3 trial, 18 patients (29%) in the orBec® group and 28 patients (42%) in the placebo group died within one year of randomization (46% reduction in mortality, hazard ratio 0.54, 95% CI: 0.30, 0.99, p=0.04, stratified log-rank test).
WIRELESS AGE COMMUNICATIONS (OTCBB: WLSA)
"Up 11.86% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/WLSA.php
Wireless Age Communications, through its 99.7% owned subsidiary, Wireless Age Communications Ltd., is in the business of operating retail cellular and telecommunications outlets in cities in western Canada. Through its other wholly owned subsidiary, Wireless Source Distribution Ltd., the company distributes two-way radio products, prepaid phone cards, wireless accessories and various battery and ancillary electronics products in Canada.
WLSA News:
January 3 - Wireless Age Achieves Record Fourth Quarter Revenues
Wireless Age Communications, Inc. (OTCBB: WLSA) ("Wireless Age") announced record unaudited consolidated revenues for the fourth quarter of fiscal 2007.
Unaudited revenues for the fourth quarter of 2007 were approximately CAD$10,844,000, compared to approximately CAD$7,871,000 during the fourth quarter of 2006, representing an increase of approximately 38%. Unaudited fiscal 2007 revenues were approximately CAD$34,666,000 compared to CAD$27,085,000 from continuing operations in 2006, representing year over year growth of 28%.
Retail segment revenues grew by 33% from approximately CAD$4,697,000 in the fourth quarter of 2006 to approximately CAD$6,232,000 in 2007. Annual retail segment revenues were up by 20% at approximately CAD$18,826,000 in 2007 and CAD$15,679,000 in 2006.
Commercial segment revenues grew by 45% from approximately CAD$3,174,000,000 in the fourth quarter of 2006 to approximately CAD$4,612,000 in 2007. Fiscal 2007 commercial segment revenues were up by 39% at approximately CAD$15,840,000 compared to CAD$11,406,000 in 2006.
Allen Cowie, Wireless Age retail segment President commented; "2007 has been a great year and the fourth quarter topped it off. Extremely strong demand was led by very aggressive cellular plan pricing launched in the Manitoba market in early November. This drove year over year post paid handset growth by over 50% and as much as 90% in some of our Manitoba locations in the months of November and December. The timing of the acquisition we made in Selkirk on November 1st could not have been better. As usual, our staff did an outstanding job in meeting the tremendous demands of a great fourth quarter. This continued growth in the wireless market was echoed in our commercial segment in particular in the cellular prepaid cards and accessory product lines."
John G. Simmonds, Wireless Age CEO stated; "This has been a pivotal year for Wireless Age. Business continues to exceed all of our expectations and we look forward to 2008 with great optimism. I want to congratulate our staff on a job well done and thank our shareholders for their loyal support during our turnaround."
ABOUT OTCPICKS.COM
OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover’s Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Disclaimer:
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.
Release of Liability:
Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has not been compensated by any of the companies covered in this release. For a complete list of disclosures go to http://www.otcpicks.com/disclosure_details.php. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor’s sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.
The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.
Third Party Web Sites and Information:
